Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 39, 2021 - Issue 8
Journal homepage
13,393
Views
184
CrossRef citations to date
0
Altmetric
Review Articles

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Anwarul Hasana Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, Qatar;b Biomedical Research Center, Qatar University, Doha, QatarCorrespondence[email protected] [email protected]
View further author information
,
Bilal Ahamad Parayc Department of Zoology, College of Science, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Arif Hussaind School of Life Sciences, Manipal Academy of Higher Education, Dubai, United Arab EmiratesView further author information
,
Fikry Ali Qadire Department of Biology, Salahaddin University-Erbil, Kurdistan Region, IraqView further author information
,
Farnoosh Attarf Faculty of Food Industry and Agriculture, Department of Biology, Standard Research Institute (SRI), Karaj, IranView further author information
,
Falah Mohammad Azize Department of Biology, Salahaddin University-Erbil, Kurdistan Region, IraqView further author information
,
Majid Sharifig Department of Nanotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran;View further author information
,
Hossein Derakhshankhahh Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, IranView further author information
,
Behnam Rastii Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, IranORCID Iconhttps://orcid.org/0000-0002-5061-3142View further author information
ORCID Icon,
Masoumeh Mehrabii Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Guilan, IranView further author information
,
Koorosh Shahpasandj Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology (RI-SCBT), Tehran, IranView further author information
,
Ali Akbar Sabouryk Institute of Biochemistry and Biophysics, University of Tehran, Tehran, IranView further author information
&
Mojtaba Falahatig Department of Nanotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran;Correspondence[email protected] [email protected]
View further author information
 show all
Pages 3025-3033 | Received 19 Mar 2020, Accepted 06 Apr 2020, Published online: 22 Apr 2020

Citations (184)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (72)

Chandran S. Abhinand, Athira A. Prabhakaran, Anand Krishnamurthy, Rajesh Raju, Thottethodi Subrahmanya Keshava Prasad, Achuthsankar S. Nair, Kallikat N. Rajasekharan, Oommen V. Oommen & Perumana R. Sudhakaran. (2023) SARS-CoV-2 variants infectivity prediction and therapeutic peptide design using computational approaches. Journal of Biomolecular Structure and Dynamics 41:20, pages 11166-11177.
Read now
Priyanka Gopi, Manisha Gurnani, Shweta Singh, Palak Sharma & Prateek Pandya. (2023) Structural aspects of SARS-CoV-2 mutations: Implications to plausible infectivity with ACE-2 using computational modeling approach. Journal of Biomolecular Structure and Dynamics 41:14, pages 6518-6533.
Read now
A.K.M. Moyeenul Huq, Miah Roney, Syahrul Imran, Shafi Ullah Khan, Md. Nazim Uddin, Thet Thet Htar, Atif Amin Baig, Mohiuddin Ahmed Bhuiyan, Zainul Amiruddin Zakaria, Mohd Fadhlizil Fasihi Mohd Aluwi & Saiful Nizam Tajuddin. (2023) Virtual screening of bioactive anti-SARS-CoV natural products and identification of 3β,12-diacetoxyabieta-6,8,11,13-tetraene as a potential inhibitor of SARS-CoV-2 virus and its infection related pathways by MD simulation and network pharmacology. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Yue Zhang, Li Zhang, Jiajing Wu, Yuanling Yu, Shuo Liu, Tao Li, Qianqian Li, Ruxia Ding, Haixin Wang, Jianhui Nie, Zhimin Cui, Yulin Wang, Weijin Huang & Youchun Wang. (2022) A second functional furin site in the SARS-CoV-2 spike protein. Emerging Microbes & Infections 11:1, pages 182-194.
Read now
D. S. N. B. K. Prasanth, Manikanta Murahari, Vivek Chandramohan, Chakravarthi Guntupalli & Lakshmana Rao Atmakuri. (2022) Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS‐CoV‐2. Journal of Biomolecular Structure and Dynamics 40:22, pages 11822-11836.
Read now
Dennis C. Copertino$suffix/text()$suffix/text(), Bruno C. Casado Lima, Rodrigo R. R. Duarte, Timothy R. Powell, Christopher E. Ormsby, Timothy Wilkin, Roy M. Gulick, Miguel de Mulder Rougvie & Douglas F. Nixon. (2022) Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection. Journal of Biomolecular Structure and Dynamics 40:16, pages 7367-7380.
Read now
Fouzia Mesli, Meriem Ghalem, Ismail Daoud & Said Ghalem. (2022) Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping. Journal of Biomolecular Structure and Dynamics 40:16, pages 7311-7323.
Read now
Amin Abbasi, Aziz Homayouni Rad, Zahra Ghasempour, Sahar Sabahi, Hossein Samadi Kafil, Paniz Hasannezhad, Yalda Rahbar Saadat & Nayyer Shahbazi. (2022) The biological activities of postbiotics in gastrointestinal disorders. Critical Reviews in Food Science and Nutrition 62:22, pages 5983-6004.
Read now
Jitender Singh, Deepti Malik & Ashvinder Raina. (2022) Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19. Journal of Biomolecular Structure and Dynamics 40:8, pages 3492-3507.
Read now
Shubham Mule, Ajit Singh, Khaled Greish, Amirhossein Sahebkar, Prashant Kesharwani & Rahul Shukla. (2022) Drug repurposing strategies and key challenges for COVID-19 management. Journal of Drug Targeting 30:4, pages 413-429.
Read now
Sagar Barage, A. Karthic, Rohit Bavi, Neetin Desai, Raj Kumar, Vikas Kumar & Keun Woo Lee. (2022) Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach. Journal of Biomolecular Structure and Dynamics 40:6, pages 2557-2574.
Read now
Marta Brambilla, Paola Canzano, Alessia Becchetti, Elena Tremoli & Marina Camera. (2022) Alterations in platelets during SARS-CoV-2 infection. Platelets 33:2, pages 192-199.
Read now
Janmejaya Rout, Bikash Chandra Swain & Umakanta Tripathy. (2022) In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:2, pages 860-874.
Read now
Zouhair Elkarhat, Hicham Charoute, Lamiae Elkhattabi, Abdelhamid Barakat & Hassan Rouba. (2022) Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses. Journal of Biomolecular Structure and Dynamics 40:1, pages 361-374.
Read now
Abdus Samad, Foysal Ahammad, Zulkar Nain, Rahat Alam, Raihan Rahman Imon, Mahadi Hasan & Md. Shahedur Rahman. (2022) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. Journal of Biomolecular Structure and Dynamics 40:1, pages 14-30.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, Ashish Kaul, Jia Wang, Huayue Zhang, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2022) Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. Journal of Biomolecular Structure and Dynamics 40:1, pages 1-13.
Read now
Sree Pooja Varahachalam, Behnaz Lahooti, Masoumeh Chamaneh, Sounak Bagchi, Tanya Chhibber, Kevin Morris, Joe F Bolanos, Nam-Young Kim & Ajeet Kaushik. (2021) Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. International Journal of Nanomedicine 16, pages 539-560.
Read now
Soumita Mukherjee, Subrata Dasgupta, Tapasendra Adhikary, Utpal Adhikari & Sujit Sankar Panja. (2021) Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. Journal of Biomolecular Structure and Dynamics 39:18, pages 7322-7334.
Read now
Hadjer Khelfaoui, Dalal Harkati & Basil A. Saleh. (2021) Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2. Journal of Biomolecular Structure and Dynamics 39:18, pages 7246-7262.
Read now
Arif Jamal Siddiqui, Sadaf Jahan, Syed Amir Ashraf, Mousa Alreshidi, Mohammad Saquib Ashraf, Mitesh Patel, Mejdi Snoussi, Ritu Singh & Mohd Adnan. (2021) Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6828-6841.
Read now
Pradeep Sharma, Viswanathan Vijayan, Pradeep Pant, Mohita Sharma, Naval Vikram, Punit Kaur, T. P. Singh & Sujata Sharma. (2021) Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6649-6659.
Read now
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour & Danial Gholamin. (2021) Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics 39:17, pages 6633-6648.
Read now
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, Dheeraj Kumar Chaurasia & Shailendra Handu. (2021) Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6617-6632.
Read now
Z. Mozafari, M. Arab Chamjangali, M. Arashi & N. Goudarzi. (2021) Suggestion of active 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents using predictive QSAR model based on the combination of ALASSO with an ANN model. SAR and QSAR in Environmental Research 32:11, pages 863-888.
Read now
Preeti Pandey, Jitendra Subhash Rane, Aroni Chatterjee, Abhijeet Kumar, Rajni Khan, Amresh Prakash & Shashikant Ray. (2021) Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Journal of Biomolecular Structure and Dynamics 39:16, pages 6306-6316.
Read now
Moussa Sehailia & Smain Chemat. (2021) Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19. Journal of Biomolecular Structure and Dynamics 39:16, pages 6184-6194.
Read now
Devashan Naidoo, Ayan Roy, Pallab Kar, Taurai Mutanda & Akash Anandraj. (2021) Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6218-6230.
Read now
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Asheet Kumar Nath, Hemant Darbari & Rajendra Joshi. (2021) Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). Journal of Biomolecular Structure and Dynamics 39:15, pages 5735-5755.
Read now
Santanu Sasidharan, Chandrabose Selvaraj, Sanjeev Kumar Singh, Vikash Kumar Dubey, Sachin Kumar, Arsenio M. Fialho & Prakash Saudagar. (2021) Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 39:15, pages 5706-5721.
Read now
Hamidreza Khodajou-Masouleh, S. Shirin Shahangian & Behnam Rasti. (2021) Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19. Drug Metabolism Reviews 53:4, pages 508-541.
Read now
Shilpa Chatterjee, Arindam Maity, Suchana Chowdhury, Md Ataul Islam, Ravi K. Muttinini & Debanjan Sen. (2021) In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme. Journal of Biomolecular Structure and Dynamics 39:14, pages 5290-5303.
Read now
Rupesh V. Chikhale, Saurabh K. Sinha, Rajesh B. Patil, Satyendra K. Prasad, Anshul Shakya, Nilambari Gurav, Rupali Prasad, Suhas R. Dhaswadikar, Manish Wanjari & Shailendra S. Gurav. (2021) In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. Journal of Biomolecular Structure and Dynamics 39:14, pages 5033-5047.
Read now
Vankudavath Raju Naik, Manne Munikumar, Ungarala Ramakrishna, Medithi Srujana, Giridhar Goudar, Pittla Naresh, Boiroju Naveen Kumar & Rajkumar Hemalatha. (2021) Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach. Journal of Biomolecular Structure and Dynamics 39:13, pages 4701-4714.
Read now
Pallab Kar, Neeta Raj Sharma, Bhupender Singh, Arnab Sen & Ayan Roy. (2021) Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics 39:13, pages 4774-4785.
Read now
Sk. Abdul Amin, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors. Journal of Biomolecular Structure and Dynamics 39:13, pages 4764-4773.
Read now
K. G. Arun, C. S Sharanya, J. Abhithaj, Dileep Francis & C. Sadasivan. (2021) Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 39:13, pages 4647-4658.
Read now
Selvaraj Alagu Lakshmi, Raja Mohamed Beema Shafreen, Arumugam Priya & Karutha Pandian Shunmugiah. (2021) Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach. Journal of Biomolecular Structure and Dynamics 39:13, pages 4594-4609.
Read now
Shashank Shekhar Mishra, Shashi Ranjan, Chandra Shekhar Sharma, Hemendra Pratap Singh, Sourav Kalra & Neeraj Kumar. (2021) Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies. Journal of Biomolecular Structure and Dynamics 39:12, pages 4449-4461.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 39:12, pages 4362-4374.
Read now
Rupesh V. Chikhale, Shailendra S. Gurav, Rajesh B. Patil, Saurabh K. Sinha, Satyendra K. Prasad, Anshul Shakya, Sushant K. Shrivastava, Nilambari S. Gurav & Rupali S. Prasad. (2021) Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach. Journal of Biomolecular Structure and Dynamics 39:12, pages 4510-4521.
Read now
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, Kapil Suchal & Shailendra Handu. (2021) Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:12, pages 4433-4448.
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Muhammad Hamza, Ashaq Ali, Suliman Khan, Saeed Ahmed, Zarlish Attique, Saad Ur Rehman, Ayesha Khan, Hussain Ali, Muhammad Rizwan, Anum Munir, Arshad Mehmood Khan, Faiza Siddique, Azhar Mehmood, Faisal Nouroz & Sajid Khan. (2021) nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. Journal of Biomolecular Structure and Dynamics 39:11, pages 4089-4099.
Read now
Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Abdulrahman L. Al-Malki, Mohammad Amjad Kamal & Vikas Kumar. (2021) Antiviral effects of probiotic metabolites on COVID-19. Journal of Biomolecular Structure and Dynamics 39:11, pages 4175-4184.
Read now
Vipul Kumar, Jaspreet Kaur Dhanjal, Sunil C. Kaul, Renu Wadhwa & Durai Sundar. (2021) Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. Journal of Biomolecular Structure and Dynamics 39:11, pages 3842-3854.
Read now
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan & Madhu Rathore. (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39:10, pages 3760-3770.
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Chinmayee Choudhury. (2021) Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease. Journal of Biomolecular Structure and Dynamics 39:10, pages 3733-3746.
Read now
K. Abraham Peele, T. Srihansa, S. Krupanidhi, Vijaya Sai Ayyagari & T. C. Venkateswarulu. (2021) Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study. Journal of Biomolecular Structure and Dynamics 39:10, pages 3793-3801.
Read now
Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy & Dong-Qing Wei. (2021) Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study. Journal of Biomolecular Structure and Dynamics 39:10, pages 3627-3637.
Read now
Saurov Mahanta, Purvita Chowdhury, Neelutpal Gogoi, Nabajyoti Goswami, Debajit Borah, Rupesh Kumar, Dipak Chetia, Probodh Borah, Alak K. Buragohain & Bhaskarjyoti Gogoi. (2021) Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach. Journal of Biomolecular Structure and Dynamics 39:10, pages 3802-3811.
Read now
Abdul Basit, Tanveer Ali & Shafiq Ur Rehman. (2021) Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent. Journal of Biomolecular Structure and Dynamics 39:10, pages 3605-3614.
Read now
Md Fulbabu Sk, Rajarshi Roy, Nisha Amarnath Jonniya, Sayan Poddar & Parimal Kar. (2021) Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics 39:10, pages 3649-3661.
Read now
Mohamed A. Hendaus. (2021) Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. Journal of Biomolecular Structure and Dynamics 39:10, pages 3787-3792.
Read now
Alireza Paniri, Mohammad Mahdi Hosseini & Haleh Akhavan-Niaki. (2021) First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. Journal of Biomolecular Structure and Dynamics 39:10, pages 3576-3593.
Read now
Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Samir Haj Bloukh, Zehra Edis, Majid Sharifi, Ehsan Kachooei & Mojtaba Falahati. (2021) The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets. Journal of Biomolecular Structure and Dynamics 39:10, pages 3780-3786.
Read now
Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Yasaman Vahdani, Samir Haj Bloukh, Majid Sharifi, Ehsan Kachooei, Setareh Haghighat & Mojtaba Falahati. (2021) Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. Journal of Biomolecular Structure and Dynamics 39:10, pages 3771-3779.
Read now
Akinwunmi O. Adeoye, Babatunde Joseph Oso, Ige Francis Olaoye, Habibu Tijjani & Ahmed I. Adebayo. (2021) Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Journal of Biomolecular Structure and Dynamics 39:10, pages 3469-3479.
Read now
Gideon A. Gyebi, Olalekan B. Ogunro, Adegbenro P. Adegunloye, Oludare M. Ogunyemi & Saheed O. Afolabi. (2021) Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics 39:9, pages 3396-3408.
Read now
Naún Lobo-Galo, Manuel Terrazas-López, Alejandro Martínez-Martínez & Ángel Gabriel Díaz-Sánchez. (2021) FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics 39:9, pages 3419-3427.
Read now
Khattab Al-Khafaji, Dunya AL-Duhaidahawi & Tugba Taskin Tok. (2021) Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:9, pages 3387-3395.
Read now
Sourav Das, Sharat Sarmah, Sona Lyndem & Atanu Singha Roy. (2021) An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics 39:9, pages 3347-3357.
Read now
Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci & Said Ghalem. (2021) In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics 39:9, pages 3263-3276.
Read now
Hussain Mustatab Wahedi, Sajjad Ahmad & Sumra Wajid Abbasi. (2021) Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics 39:9, pages 3225-3234.
Read now
Saurabh K. Sinha, Anshul Shakya, Satyendra K. Prasad, Shashikant Singh, Nilambari S. Gurav, Rupali S. Prasad & Shailendra S. Gurav. (2021) An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics 39:9, pages 3244-3255.
Read now
Rajib Islam, Md. Rimon Parves, Archi Sundar Paul, Nizam Uddin, Md. Sajjadur Rahman, Abdulla Al Mamun, Md. Nayeem Hossain, Md. Ackas Ali & Mohammad A. Halim. (2021) A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:9, pages 3213-3224.
Read now
Abdo A. Elfiky. (2021) SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. Journal of Biomolecular Structure and Dynamics 39:9, pages 3204-3212.
Read now
Abdo A. Elfiky. (2021) Natural products may interfere with SARS-CoV-2 attachment to the host cell. Journal of Biomolecular Structure and Dynamics 39:9, pages 3194-3203.
Read now
Rakesh S. Joshi, Shounak S. Jagdale, Sneha B. Bansode, S. Shiva Shankar, Meenakshi B. Tellis, Vaibhav Kumar Pandya, Anita Chugh, Ashok P. Giri & Mahesh J. Kulkarni. (2021) Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics 39:9, pages 3099-3114.
Read now
Subramanian Boopathi, Adolfo B. Poma & Ponmalai Kolandaivel. (2021) Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics 39:9, pages 3409-3418.
Read now
Piotr H Pawłowski. (2021) Additional Positive Electric Residues in the Crucial Spike Glycoprotein S Regions of the New SARS-CoV-2 Variants. Infection and Drug Resistance 14, pages 5099-5105.
Read now
Hassan Ih El-Sayyad & Yousef Ka Abdalhafid. (2020) COVID-19;-The origin, genetics,and management of the infection of mothers and babies. Egyptian Journal of Basic and Applied Sciences 7:1, pages 371-388.
Read now

Articles from other publishers (112)

Abrar Asif, Muhammad Afzaal, Hina Shahid, Farhan Saeed, Aftab Ahmed, Yasir Abbas Shah, Afaf Ejaz, Samia Ghani, Huda Ateeq & Mahbubur Rahman Khan. (2023) Probing the functional and therapeutic properties of postbiotics in relation to their industrial application. Food Science & Nutrition 11:8, pages 4472-4484.
Crossref
Ioannis Pantazopoulos, Athanasios Chalkias, Angeliki Miziou, Michalis Spanos, Efrosyni Gerovasileiou, Erasmia Rouka & Konstantinos Gourgoulianis. (2023) A Hypertonic Seawater Nasal Irrigation Solution Containing Algal and Herbal Natural Ingredients Reduces Viral Load and SARS-CoV-2 Detection Time in the Nasal Cavity. Journal of Personalized Medicine 13:7, pages 1093.
Crossref
Kavitha KSrinivasan NSuresh RMohan S. (2023) In Silico Identification of Potential Inhibitors of Substituted Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2. Research Journal of Pharmacy and Technology, pages 2470-2476.
Crossref
Ting Li, Jiewen Fu, Jingliang Cheng, Abdo A. Elfiky, Chunli Wei & Junjiang Fu. (2023) New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Frontiers in Immunology 14.
Crossref
Jun Tamiya, Wakako Sakaguchi, Kimiko Nakagawa, Toshiharu Yamamoto, Juri Saruta, Nobuhisa Kubota, Akira Kawata, Iwao Hasegawa, Nobushiro Hamada & Keiichi Tsukinoki. (2023) Detection of SARS-CoV-2 and Its Related Factors on the Mucosal Epithelium of the Tongue. ACTA HISTOCHEMICA ET CYTOCHEMICA 56:2, pages 29-37.
Crossref
Tenzin Yangchen, Farrukh M. Koraishy, Chang Xu, Wei Hou & Rajeev Rohatgi. (2023) Initial mean arterial blood pressure (MABP) measurement is a risk factor for mortality in hypertensive COVID-19 positive hospitalized patients. PLOS ONE 18:3, pages e0283331.
Crossref
Iktedar Mahdi, Humyara Yeasmin, Imtiaz Hossain, Raina Masnoon Badhan, Md. Ackas Ali, Md. Abdul Kaium, Rajib Islam, Md. Abu Sufian & Mohammad A. Halim. (2022) Potential antiviral peptides against the nucleoprotein of SARS-CoV-2. Chemical Papers 77:2, pages 813-823.
Crossref
Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling-Pils, Markus Hoffmann, Tatjana Lüddecke, Felicitas Miller, Lars Melcher, Amy M. Kempf, Inga Nehlmeier, Dunja Bruder, Marek Widera, Sandra Ciesek, Stefan Pöhlmann & Luka Čičin-Šain. (2023) TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection. Viruses 15:2, pages 271.
Crossref
Syed Nasir Abbas Bukhari, Naveed Ahmed, Muhammad Wahab Amjad, Muhammad Ajaz Hussain, Mervat A. Elsherif, Hasan Ejaz & Nasser H. Alotaibi. (2023) Covalent Organic Frameworks (COFs) as Multi-Target Multifunctional Frameworks. Polymers 15:2, pages 267.
Crossref
Paul C. Guest, Prashant Kesharwani, Alexandra E. Butler & Amirhossein Sahebkar. 2023. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19. Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19 3 26 .
Andrea Lorena Delgado-Betancourt, Maria Helena Zuñiga-Lopez & Juan Pablo García-López. (2022) Análisis in silico de la inmunogenicidad e interacción molecular de péptidos de plantas aromáticas con SARS-CoV-2. Revista de la Asociación Colombiana de Ciencias Biológicas, pages 93-104.
Crossref
Jiayue He, Shuguang Liu, Qi Tan, Zhiying Liu, Jiewen Fu, Ting Li, Chunli Wei, Xiaoyan Liu, Zhiqiang Mei, Jingliang Cheng, Kai Wang & Junjiang Fu. (2022) Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17. Molecules 27:24, pages 9044.
Crossref
Acharya Balkrishna, Subarna Pokhrel & Anurag Varshney. (2022) Phyto-Compounds from a Rather Poisonous Plant, Strychnos nuxvomica , Show High Potency Against SARS-CoV-2 RNA-Dependent RNA Polymerase . Current Molecular Medicine 22:10, pages 929-940.
Crossref
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Marquez, Kawthar Mohamed, Lamin Ndow, Dorota Zarębska-Michaluk, Nima Rezaei & Piotr Rzymski. (2022) Oral antiviral treatments for COVID-19: opportunities and challenges. Pharmacological Reports 74:6, pages 1255-1278.
Crossref
Ibrahim A. Shehu, Muhammad K. Musa, Aparna Datta & Amita Verma. (2022) Application of Nanotechnology in COVID-19 Infection: Findings and Limitations. Journal of Nanotheranostics 3:4, pages 203-232.
Crossref
Yixuan Hao, Maozi Chen, Yasmin Othman, Xiang-Qun Xie & Zhiwei Feng. (2022) Virus-CKB 2.0: Viral-Associated Disease-Specific Chemogenomics Knowledgebase. ACS Omega 7:42, pages 37476-37484.
Crossref
Aurelia Magdalena Pisoschi, Florin Iordache, Loredana Stanca, Iuliana Gajaila, Oana Margarita Ghimpeteanu, Ovidiu Ionut Geicu, Liviu Bilteanu & Andreea Iren Serban. (2022) Antioxidant, Anti-inflammatory, and Immunomodulatory Roles of Nonvitamin Antioxidants in Anti-SARS-CoV-2 Therapy. Journal of Medicinal Chemistry 65:19, pages 12562-12593.
Crossref
Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, Roberto Tonelli, Stefania Cerri, Enrico Clini, Franco Stella & Massimo Dominici. (2022) Biological effects of COVID-19 on lung cancer: Can we drive our decisions. Frontiers in Oncology 12.
Crossref
Shiv Kumar Prajapati, Akanksha Malaiya, Gaurav Mishra, Dolly Jain, Payal Kesharwani, Nishi Mody, Amirhossein Ahmadi, Rishi Paliwal & Ankit Jain. (2022) An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations. Journal of Ethnopharmacology 296, pages 115420.
Crossref
Jeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Francesca Colombo, Gabriela Cuevas Barron, María Fernanda Espinosa, Vitor Gaspar, Alejandro Gaviria, Andy Haines, Peter J Hotez, Phoebe Koundouri, Felipe Larraín Bascuñán, Jong-Koo Lee, Muhammad Ali Pate, Gabriela Ramos, K Srinath Reddy, Ismail Serageldin, John Thwaites, Vaira Vike-Freiberga, Chen Wang, Miriam Khamadi Were, Lan Xue, Chandrika Bahadur, Maria Elena Bottazzi, Chris Bullen, George Laryea-Adjei, Yanis Ben Amor, Ozge Karadag, Guillaume Lafortune, Emma Torres, Lauren Barredo, Juliana G E Bartels, Neena Joshi, Margaret Hellard, Uyen Kim Huynh, Shweta Khandelwal, Jeffrey V Lazarus & Susan Michie. (2022) The Lancet Commission on lessons for the future from the COVID-19 pandemic. The Lancet 400:10359, pages 1224-1280.
Crossref
I. Pantazopoulos, A. Chalkias, G. Mavrovounis, I. Dimeas, S. Sinis, A. Miziou, E. Rouka, K. Poulas & K. Gourgoulianis. (2022) Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial. Canadian Respiratory Journal 2022, pages 1-6.
Crossref
Meng Zhang, Yanchao He & Zhijun Jie. (2022) Delta variant: Partially sensitive to vaccination, but still worth global attention. Journal of Translational Internal Medicine 10:3, pages 227-235.
Crossref
Abigarl Ndudzo, Sakhile Ndlovu, Nesisa Nyathi & Angela Sibanda Makuvise. 2022. The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions. The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions.
Maria Eleonora Bizzoca, Stefania Leuci, Michele Davide Mignogna, Eleonora Lo Muzio, Vito Carlo Alberto Caponio & Lorenzo Lo Muzio. (2022) Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review. Food Science and Human Wellness 11:5, pages 1134-1142.
Crossref
Hedyieh Karbasforooshan, Sofia Salari & Hesamoddin Hosseinjani. (2022) A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019. Infectious Disorders - Drug Targets 22:5.
Crossref
Chen SunHangyuan ZhaoYunze HanYiqing WangXiao Sun. (2022) The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets. Journal of Interferon & Cytokine Research 42:8, pages 406-420.
Crossref
Basem Al-Omari, Tauseef Ahmad & Rami H. Al-Rifai. (2022) SARS-CoV-2 and COVID-19 Research Trend during the First Two Years of the Pandemic in the United Arab Emirates: A PRISMA-Compliant Bibliometric Analysis. International Journal of Environmental Research and Public Health 19:13, pages 7753.
Crossref
Naveen Vankadari, Vijayasarathy Ketavarapu, Sasikala Mitnala, Ravikanth Vishnubotla, Duvvur Nageshwar Reddy & Debnath Ghosal. (2022) Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics. The Journal of Physical Chemistry Letters, pages 5324-5333.
Crossref
Kai Wang, Haoyue Deng, Binghui Song, Jiayue He, Shuguang Liu, Jiewen Fu, Lianmei Zhang, Dabing Li, Kyathegowdanadoddi Srinivasa Balaji, Zhiqiang Mei, Jingliang Cheng & Junjiang Fu. (2022) The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. Frontiers in Immunology 13.
Crossref
Nader Khani, Roya Abedi Soleimani, Ghasem Noorkhajavi, Azar Abedi Soleimani, Amin Abbasi & Aziz Homayouni Rad. (2022) Postbiotics as potential promising tools for SARS-CoV-2 disease adjuvant therapy. Journal of Applied Microbiology 132:6, pages 4097-4111.
Crossref
Bakr Ahmed Taha, Qussay Al-Jubouri, Yousif Al Mashhadany, Mohd Saiful Dzulkefly Bin Zan, Ahmad Ashrif A. Bakar, Mahmoud Muhanad Fadhel & Norhana Arsad. (2022) Photonics enabled intelligence system to identify SARS-CoV 2 mutations. Applied Microbiology and Biotechnology 106:9-10, pages 3321-3336.
Crossref
Nourhan M. Abd El-Aziz, Ibrahim Khalifa, Amira M. G. Darwish, Ahmed N. Badr, Huda Aljumayi, El-Sayed Hafez & Mohamed G. Shehata. (2022) Docking Analysis of Some Bioactive Compounds from Traditional Plants against SARS-CoV-2 Target Proteins. Molecules 27:9, pages 2662.
Crossref
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu & Vasso Apostolopoulos. (2022) A global picture: therapeutic perspectives for COVID-19. Immunotherapy 14:5, pages 351-371.
Crossref
Behzad Shahbazi, Ladan Mafakher & Ladan Teimoori-Toolabi. (2022) Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study. Journal of Molecular Modeling 28:4.
Crossref
Javad Razjouyan, Drew A Helmer, Kristine E Lynch, Nicola A Hanania, Paul E Klotman, Amir Sharafkhaneh & Christopher I Amos. (2022) Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine & Tobacco Research 24:5, pages 785-793.
Crossref
Rumiana Tenchov & Qiongqiong Angela Zhou. (2022) Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery. ACS Infectious Diseases 8:3, pages 422-432.
Crossref
J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi & Manoocher Soleimani. (2022) Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets. International Journal of Molecular Sciences 23:4, pages 2242.
Crossref
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Fabio Piras, Vito Settanni, Grazia Garofoli, Giulia Palmieri, Sabino Ceci, Assunta Patano, Antonio Mancini, Luigi Vimercati, Damiano Nemore, Arnaldo Scardapane, Biagio Rapone, Alexandra Semjonova, Maria Teresa D’Oria, Luigi Macchia, Ioana Roxana Bordea, Giovanni Migliore, Antonio Scarano, Felice Lorusso, Gianluca Martino Tartaglia, Delia Giovanniello, Ludovica Nucci, Nicola Maggialetti, Antonio Parisi, Marina Di Domenico, Nicola Brienza, Silvio Tafuri, Pasquale Stefanizzi, Luigi Curatoli, Alberto Corriero, Maria Contaldo, Francesco Inchingolo & Gianna Dipalma. (2022) COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines. Children 9:2, pages 249.
Crossref
Hriday Kumar Basak, Soumen Saha, Joydeep Ghosh, Uttam Paswan, Sujoy Karmakar, Ayon Pal & Abhik Chatterjee. (2022) Sequence Analysis, Structure Prediction of Receptor Proteins and In Silico Study of Potential Inhibitors for Management of Life Threatening COVID-19. Letters in Drug Design & Discovery 19:2, pages 108-122.
Crossref
R. Clayton Edenfield & Charles A. EasleyIVIV. (2021) Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function. Nature Reviews Urology 19:2, pages 116-127.
Crossref
Alireza Noruzi, Behzad Gholampour, Sajad Gholampour, Somayeh Jafari, Razieh Farshid, Agata Stanek & Ali Akbar Saboury. (2022) Current and Future Perspectives on the COVID-19 Vaccine: A Scientometric Review. Journal of Clinical Medicine 11:3, pages 750.
Crossref
May Nasser Bin-Jumah, Muhammad Shahid Nadeem, Sadaf Jamal Gilani, Bismillah Mubeen, Inam Ullah, Sami I. Alzarea, Mohammed M. Ghoneim, Sultan Alshehri, Fahad A. Al-Abbasi & Imran Kazmi. (2022) Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases. Antioxidants 11:2, pages 232.
Crossref
Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos & Hong Yu. (2022) Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp). Current Medicinal Chemistry 29:1, pages 152-162.
Crossref
Shivani Malviya, Arpana Parihar, Dipesh Singh Parihar & Raju Khan. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection 115 145 .
Mahreen Arooj, Ihsan Shehadi, Chahlaa N. Nassab & Ahmed A. Mohamed. (2021) Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets. Chemical Papers 76:1, pages 111-121.
Crossref
Noor ul Amin Mohsin, Muhammad Irfan & Muhammad Naeem Aamir. (2021) In Silico Approaches for Novel Drug Discovery Against Coronavirus by Employing the Hybrid Molecular Technique: A Review . Journal of Computational Biophysics and Chemistry 20:07, pages 667-674.
Crossref
Fengsheng Chien, Quang-Thanh Ngo, Ching-Chi Hsu, Ka Yin Chau & Robina Iram. (2021) Assessing the mechanism of barriers towards green finance and public spending in small and medium enterprises from developed countries. Environmental Science and Pollution Research 28:43, pages 60495-60510.
Crossref
Mahdie Rahban, Agata Stanek, Amirreza Hooshmand, Yasaman Khamineh, Salma Ahi, Syed Naqui Kazim, Faizan Ahmad, Vladimir Muronetz, Mohamed Samy Abousenna, Samaneh Zolghadri & Ali A. Saboury. (2021) Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. Journal of Clinical Medicine 10:21, pages 4802.
Crossref
Taj Mohammad, Arunabh Choudhury, Insan Habib, Purva Asrani, Yash Mathur, Mohd Umair, Farah Anjum, Alaa Shafie, Dharmendra Kumar Yadav & Md. Imtaiyaz Hassan. (2021) Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai & Dinesh Kumar. (2021) Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Frontiers in Chemistry 9.
Crossref
Khalil EL Khatabi, Ilham Aanouz, Marwa Alaqarbeh, Mohammed Aziz Ajana, Tahar Lakhlifi & Mohammed Bouachrine. (2021) Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (M Pro ) . BioImpacts 12:2, pages 107-113.
Crossref
Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Luigi Santacroce, Grazia Marinelli, Antonio Mancini, Luigi Vimercati, Maria Elena Maggiore, Maria Teresa D’Oria, Denisa Hazballa, Ioana Roxana Bordea, Edit Xhajanka, Antonio Scarano, Marco Farronato, Gianluca Martino Tartaglia, Delia Giovanniello, Ludovica Nucci, Rosario Serpico, Gilberto Sammartino, Loredana Capozzi, Antonio Parisi, Marina Di Domenico, Felice Lorusso, Maria Contaldo, Francesco Inchingolo & Gianna Dipalma. (2021) COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies. Microorganisms 9:9, pages 1964.
Crossref
Debadash Panigrahi. (2021) Molecular Docking Analysis of the Phytochemicals from Tinospora Cordifolia as Potential Inhibitor Against Multi Targeted SARS-CoV-2 & Cytokine Storm . Journal of Computational Biophysics and Chemistry 20:06, pages 559-580.
Crossref
Suzy Huijghebaert, Levi Hoste & Guido Vanham. (2021) Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19. European Journal of Clinical Pharmacology 77:9, pages 1275-1293.
Crossref
Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed & Mohammadreza Ardalan. (2021) Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza. Frontiers in Molecular Biosciences 8.
Crossref
Md. Sirazul Islam, F. M. Yasir Hasib, Chandan Nath, Jahan Ara, Mong Sing Nu, Md. Abul Fazal & Sharmin Chowdhury. (2021) Coronavirus disease 2019 and its potential animal reservoirs: A review. International Journal of One Health, pages 171-181.
Crossref
Christopher Dayaramani, Joshua De Leon & Allison B. Reiss. (2021) Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina 57:8, pages 833.
Crossref
Keshav S. Moharir, Sumit K. Arora, Subhash R. Yende, Govind K. Lohiya & Sapan K. Shah. (2021) Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review. The Open COVID Journal 1:1, pages 65-76.
Crossref
Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Olorunfemi R. Molehin & Courage D. Famusiwa. (2021) Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation. In Silico Pharmacology 9:1.
Crossref
Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Emilie Delattre, Pierre-Alexandre Fonta, Jan Krepl, Stanislav Schmidt, Daniel Keller, Samuel Kerrien, Enrico Scantamburlo, Anna-Kristin Kaufmann & Henry Markram. (2021) A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Frontiers in Public Health 9.
Crossref
Jacob M. Remington, Kyle T. McKay, Jonathon B. Ferrell, Severin T. Schneebeli & Jianing Li. (2021) Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein. Biophysical Journal 120:14, pages 2848-2858.
Crossref
Uttpal Anand, Shweta Jakhmola, Omkar Indari, Hem Chandra Jha, Zhe-Sheng Chen, Vijay Tripathi & José M. Pérez de la Lastra. (2021) Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Frontiers in Immunology 12.
Crossref
Yan Wang, Zhen Wu, Wenhua Hu, Piliang Hao & Shuang Yang. (2021) Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein. ACS Omega 6:24, pages 15988-15999.
Crossref
Wataru Nishima & Marta Kulik. (2021) Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism. Viruses 13:6, pages 1126.
Crossref
Carolin LangnauAnne-Katrin Rohlfing, Sarah GekelerManina GünterSimone PöschelÁlvaro Petersen-UribePhilippa JaegerAlban AvdiuTobias HarmKlaus-Peter KreisselmeierTatsiana CastorTamam BakchoulDominik RathMeinrad Paul Gawaz, Stella E. Autenrieth & Karin Anne Lydia Mueller. (2021) Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19. Arteriosclerosis, Thrombosis, and Vascular Biology 41:6, pages 2080-2096.
Crossref
Naser Gharebaghi, Saman Farshid, Behdad Boroofeh, Rahim Nejadrahim, Jalil Mousavi, Sina Dindarian & Sedra Mohammadi. (2021) Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province. International Journal of Clinical Practice 75:6.
Crossref
Mohsen Sisakht, Amir Mahmoodzadeh & Maryam Darabian. (2021) Plant‐derived chemicals as potential inhibitors of SARS‐CoV ‐2 main protease ( 6LU7 ), a virtual screening study . Phytotherapy Research 35:6, pages 3262-3274.
Crossref
Alessio Danilo Inchingolo, Gianna Dipalma, Angelo Michele Inchingolo, Giuseppina Malcangi, Luigi Santacroce, Maria Teresa D’Oria, Ciro Gargiulo Isacco, Ioana Roxana Bordea, Sebastian Candrea, Antonio Scarano, Benedetta Morandi, Massimo Del Fabbro, Marco Farronato, Gianluca Martino Tartaglia, Mario Giosuè Balzanelli, Andrea Ballini, Ludovica Nucci, Felice Lorusso, Silvio Taschieri & Francesco Inchingolo. (2021) The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants 10:6, pages 881.
Crossref
Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antonio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco, Grazia Marinelli, Maria Teresa D’Oria, Denisa Hazballa, Luigi Santacroce, Andrea Ballini, Maria Contaldo, Francesco Inchingolo & Gianna Dipalma. (2021) SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms 9:4, pages 793.
Crossref
Abdurrahim Kocyigit, Ozgur Sogut, Ezgi Durmus, Ebru Kanimdan, Eray Metin Guler, Onur Kaplan, Vildan Betul Yenigun, Canan Eren, Zeynep Ozman & Oznur Yasar. (2021) Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2–infected patients. Science Progress 104:2_suppl, pages 003685042110261.
Crossref
Dhanusha Yesudhas, Ambuj Srivastava & M. Michael Gromiha. (2020) COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 49:2, pages 199-213.
Crossref
SABYASACHI SENAPATI, PRATIBHA BANERJEE, SANDILYA BHAGAVATULA, PREM PRAKASH KUSHWAHA & SHASHANK KUMAR. (2021) Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19. Journal of Genetics 100:1.
Crossref
Krishan Gupta, Sanjay Kumar Mohanty, Aayushi Mittal, Siddhant Kalra, Suvendu Kumar, Tripti Mishra, Jatin Ahuja, Debarka Sengupta & Gaurav Ahuja. (2021) The Cellular basis of loss of smell in 2019-nCoV-infected individuals. Briefings in Bioinformatics 22:2, pages 873-881.
Crossref
Omkar Indari, Shweta Jakhmola, Elangovan Manivannan & Hem Chandra Jha. (2021) An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?. Frontiers in Pharmacology 12.
Crossref
Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antonio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco, Grazia Marinelli, Maria Teresa D’Oria, Denisa Hazballa, Luigi Santacroce, Andrea Ballini, Maria Contaldo, Francesco Inchingolo & Gianna Dipalma. (2021) SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 9:3, pages 525.
Crossref
Pasqua Anna Quitadamo, Laura Comegna & Pierpaolo Cristalli. (2021) Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19. Frontiers in Public Health 8.
Crossref
G.C. Fernández-Pérez, M. Oñate Miranda, P. Fernández-Rodríguez, M. Velasco Casares, M. Corral de la Calle, Á. Franco López, M. Díez Blanco & J.M. Oñate Cuchat. (2021) SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies. Radiología (English Edition) 63:2, pages 115-126.
Crossref
G.C. Fernández-Pérez, M. Oñate Miranda, P. Fernández-Rodríguez, M. Velasco Casares, M. Corral de la Calle, Á. Franco López, M. Díez Blanco & J.M. Oñate Cuchat. (2021) SARS-CoV-2: cómo es, cómo actúa y cómo se expresa en la imagen. Radiología 63:2, pages 115-126.
Crossref
Raj Kumar, Vikas Kumar & Keun Woo Lee. (2021) A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment. Computers in Biology and Medicine 130, pages 104186.
Crossref
U. Rutwick Surya & N. Praveen. (2021) A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. VirusDisease 32:1, pages 46-54.
Crossref
Saber Soltani, Armin Zakeri, Milad Zandi, Mina Mobini Kesheh, Alireza Tabibzadeh, Mahsa Dastranj, Samireh Faramarzi, Mojtaba Didehdar, Hossein Hafezi, Parastoo Hosseini & Abbas Farahani. (2021) The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients. BioMed Research International 2021, pages 1-13.
Crossref
Marzieh Omrani, Mohsen Keshavarz, Samad Nejad Ebrahimi, Meysam Mehrabi, Lyndy J. McGaw, Muna Ali Abdalla & Parvaneh Mehrbod. (2021) Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines. Frontiers in Pharmacology 11.
Crossref
Stéphane Derruau, Jérôme Bouchet, Ali Nassif, Alexandre Baudet, Kazutoyo Yasukawa, Sandrine Lorimier, Isabelle Prêcheur, Agnès Bloch-Zupan, Bernard Pellat, Hélène Chardin & Sophie Jung. (2021) COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. Journal of Clinical Medicine 10:4, pages 779.
Crossref
Majid Sharifi, Anwarul Hasan, Setareh Haghighat, Akbar Taghizadeh, Farnoosh Attar, Samir Haj Bloukh, Zehra Edis, Mengzhou Xue, Suliman Khan & Mojtaba Falahati. (2021) Rapid diagnostics of coronavirus disease 2019 in early stages using nanobiosensors: Challenges and opportunities. Talanta 223, pages 121704.
Crossref
Reham M. Dawood, Mai A. El-Meguid, Ghada M. Salum, Khaled El-Wakeel, Mohamed Shemis & Mostafa K. El Awady. (2021) Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2. Journal of Infection and Public Health 14:2, pages 169-178.
Crossref
Drashti Desai & Pravin Shende. (2020) Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19. Stem Cell Reviews and Reports 17:1, pages 231-240.
Crossref
Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis & Alexios-Leandros Skaltsounis. (2021) Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 26:2, pages 448.
Crossref
Endah Puji Septisetyani, Pekik Wiji Prasetyaningrum, Khairul Anam & Adi Santoso. (2021) SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD. Immune Network 21:6.
Crossref
Jose J. Naveja, Abraham Madariaga-Mazón, Francisco Flores-Murrieta, Julio Granados-Montiel, Marco Maradiaga-Ceceña, Víctor Duarte Alaniz, Maricruz Maldonado-Rodriguez, Jazmín García-Morales, Juan Pablo Senosiain-Peláez & Karina Martinez-Mayorga. (2021) Union is strength: antiviral and anti-inflammatory drugs for COVID-19. Drug Discovery Today 26:1, pages 229-239.
Crossref
Yin Yao, Hai Wang & Zheng Liu. (2020) Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clinical & Experimental Allergy 50:12, pages 1313-1324.
Crossref
Kuppuswamy Kavitha, Subramaniam Sivakumar & Balasubramanian Ramesh. (2020) 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates. Biophysical Chemistry 267, pages 106478.
Crossref
Ambrish Saxena. (2020) Drug targets for COVID-19 therapeutics: Ongoing global efforts. Journal of Biosciences 45:1.
Crossref
Zainab Sarwar, Tahir Ahmad & Salik Kakar. (2020) Potential approaches to combat COVID-19: a mini-review. Molecular Biology Reports 47:12, pages 9939-9949.
Crossref
Naveen Vankadari, Nandhini Nisha Jeyasankar & Wilma Jerom Lopes. (2020) Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence. The Journal of Physical Chemistry Letters 11:22, pages 9659-9668.
Crossref
Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria E. Campillo & Ana Martinez. (2020) COVID-19: Drug Targets and Potential Treatments. Journal of Medicinal Chemistry 63:21, pages 12359-12386.
Crossref
Shalki Choudhary & Om Silakari. (2020) Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Virus Research 289, pages 198146.
Crossref
J. Porta-Etessam, M. Yus, N. González García, A. Valcarcel, J. Barrado-Cuchillo & J. Pérez-Somarriba. (2020) Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection. Neurología 35:9, pages 701-703.
Crossref
Dipak Kumar Sahu, Deepak Pradhan, Pradeep Kumar Naik, Biswakanth Kar, Goutam Ghosh & Goutam Rath. (2020) Smart polymeric eye gear: A possible preventive measure against ocular transmission of COVID-19. Medical Hypotheses 144, pages 110288.
Crossref
Ángel Estella & Jose Garnacho-Montero. (2020) From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic. Medicina Intensiva (English Edition) 44:8, pages 509-512.
Crossref
Á. Estella & J. Garnacho-Montero. (2020) Del empirismo a la evidencia científica en el tratamiento con antivíricos en los casos graves de infección por coronavirus en tiempos de epidemia. Medicina Intensiva 44:8, pages 509-512.
Crossref
Rubal Singla, Abhishek Mishra, Rupa Joshi, Sonali Jha, Amit Raj Sharma, Sujata Upadhyay, Phulen Sarma, Ajay Prakash & Bikash Medhi. (2020) Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Veterinary Research Communications 44:3-4, pages 119-130.
Crossref
Rahsan Ilikci Sagkan & Dilara Fatma Akin‐Bali. (2020) Structural variations and expression profiles of the SARS‐CoV‐2 host invasion genes in lung cancer. Journal of Medical Virology 92:11, pages 2637-2647.
Crossref
Xueqin DongZhenxue TianChengwu ShenCuirong Zhao. (2020) An overview of potential therapeutic agents to treat COVID-19. BioScience Trends 14:5, pages 318-327.
Crossref
Ioana Roxana Bordea, Edit Xhajanka, Sebastian Candrea, Simion Bran, Florin Onișor, Alessio Danilo Inchingolo, Giuseppina Malcangi, Van H Pham, Angelo Michele Inchingolo, Antonio Scarano, Felice Lorusso, Ciro Gargiulo Isacco, Sergey K Aityan, Andrea Ballini, Gianna Dipalma & Francesco Inchingolo. (2020) Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners. Microorganisms 8:11, pages 1704.
Crossref
Robin Augustine, Suvarthi Das, Anwarul Hasan, Abhilash S, Shaheen Abdul Salam, Priya Augustine, Yogesh Bharat Dalvi, Ruby Varghese, Rosita Primavera, Hadi Mohamad Yassine, Avnesh S. Thakor & Bhavesh D. Kevadiya. (2020) Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World. Journal of Clinical Medicine 9:10, pages 3372.
Crossref
Ramarao Poduri, Gaurav Joshi & Gowraganahalli Jagadeesh. (2020) Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Cellular Signalling 74, pages 109721.
Crossref
P. Chellapandi & S. Saranya. (2020) Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Medicinal Chemistry Research 29:10, pages 1777-1791.
Crossref
Giada Pontecorvi, Maria Bellenghi, Elena Ortona & Alessandra Carè. (2020) microRNAs as new possible actors in gender disparities of Covid‐19 pandemic. Acta Physiologica 230:1.
Crossref
Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, Juri Saruta, Shinya Fuchida, Akira Kawata, Yuko Yamamoto, Masahiro Sugimoto, Mayumi Yakeishi & Keiichi Tsukinoki. (2020) Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity. International Journal of Molecular Sciences 21:17, pages 6000.
Crossref
Naveen Vankadari. (2020) Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence. The Journal of Physical Chemistry Letters 11:16, pages 6655-6663.
Crossref
Ayse Basak Engin, Evren Doruk Engin & Atilla Engin. (2020) Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Environmental Toxicology and Pharmacology 78, pages 103411.
Crossref
Matilde Hoffman, DeGaulle I. Chigbu, Brenndan L. Crumley, Ravi Sharma, Sergey Pustylnikov, Thomas Crilley, Rashida Ginwala, Ronak Loonawat, Julie Joseph, Dominic Sales, Sydney Wilson & Pooja Jain. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control 1 120 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.